• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Cell Viability Assays and Consumables

Cell Viability Assays and Consumables: Global Markets


Summary

Cell viability assays refer to a homogeneous method to determine the number of viable cells within a culture. Cell viability measurements are used to evaluate the effectiveness of a drug candidate, rejection of implanted organs or evaluation of the life or death of cancerous cells. Cell viability assays are used in clinical and diagnostic applications, drug discovery and development, stem cell research, basic research and other applications such as toxicity testing and tissue engineering. Cell viability assays have proven to be extremely beneficial in drug discovery applications and the global cell viability assays market is projected to see rapid growth during the forecast period (2018-2023) owing to increasing emphasis on stem cell research and increasing demand for cell-based assays in research and development.

A surge in the number of potential biomarkers candidates for cell-based assays, growing incidence of infectious and chronic diseases and increasing focus on developing cell-based therapeutics are some of the major factors that are expected to promote the growth of global cell viability assays market. In addition, factors such as increasing healthcare expenditures and the global aging population are also providing traction for the global cell viability assays market growth during the forecast period. The growing prevalence of infectious and chronic diseases is considered to be the major driver behind the growth of the cell viability assays market. Cell viability measurements are used to evaluate the
effectiveness of a drug candidate, rejection of implanted organs or the life or death of cancerous cells.

According to the World Health Organization (WHO), the number of patients suffering from chronic diseases such as respiratory disease, cancer and cardiovascular disease totaled about 130 million people in 2005 and is expected to reach REDACTED by 2030. In addition, increasing emphasis on stem cell research is also poised to generate strong growth opportunities for cell viability assays. Governments globally are investing huge amounts on stem cell research. According to the U.S. Department of Health and Human Services, REDACTED billion was spent on stem cell research in 2016; this increased to REDACTED in 2017. In April 2017, Bayer AG and Versant Ventures (U.S.) announced plans to invest REDACTED to launch a stem cell research company in Canada and create a global hub for regenerative-medicinetherapies.

The global cell viability assays market is projected to rise at a compound annual growth rate (CAGR) of REDACTED during the forecast period of 2018 through 2023. Market value is expected to rise from REDACTED in 2018 to REDACTED by 2023. Consumables held REDACTED of the market in 2017 in terms of revenue. By 2023, total revenue from consumables is expected to see a CAGR of REDACTED.	
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Introduction
Market Potential
Market Size and Growth
Consumer Types and Product Success
Competitor Pricing
Regulatory Framework
United States
European Union
China
India
Japan
Australia
Brazil
Russia
Investment Analysis
Industry Growth Drivers
Increasing Focus on Development of Cell-Based Therapeutics and Potential Biomarkers
Growing Prevalence and Incidence of Infectious and Chronic Diseases
Increasing Demand for Cell-Based Assays in Research and Development
Increasing Emphasis on Stem Cell Research
Chapter 4 Cell Viability Assays Market by Product
Instruments
Automated Cell Counters
Flow Cytometers
Spectrophotometers
Cell Imaging and Analysis Systems
Consumables
Reagents
Assay Kits
Microplates
Chapter 5 Market Breakdown by Cell Type
Human Cells
Assays to Measure Viable Cells
Benefits of Protease Marker Assays
Advantages of ATP Assays
ATP Cell Viability Assay for Measuring Intrinsic Radio-Sensitivity in Cervical Cancer
Animal Cells
Advantages of Viability Assays for Animals
Microbial Cells
Cell Viability Assay to Determine the Cytotoxic Effects by Microbes in Water
Imaging Microbial Viability Assays
Imaging Biofilm Viability Assays
Bacterial Viability Assays for Flow Cytometry
Viability Detection of Foodborne Microbial Pathogens
Global Estimates of Foodborne Diseases
Chapter 6 Market Breakdown by Application
Clinical and Diagnostic Applications
Drug Discovery and Development
Stem Cell Research
Potential Benefits of Stem Cell Research
Basic Research
Other Applications (e.g., Toxicity Testing, Tissue Engineering)
Toxicity Testing
Tissue Engineering
Chapter 7 Market Breakdown by End User
Academic and Research Institutions
Market Drivers
Pharmaceutical and Biotechnology Companies
UV-Spectrophotometers for Drug Stability Testing
Market Drivers
Hospitals and Diagnostic Laboratories
Cell Viability Assays
Assays and Their Substrates
Technological Advancements and Innovations
XTT Formazan Assay to Detect Cell Viability Inhibits HIV Type 1 Infection
Viability Assay to Identify Biologically-Relevant Malaria Transmission- Blocking Drugs
Assays for Diagnostic Tests for Malaria
Non-Blood Based Assays
Blood-Based Assays
Other End Users
Cancer Diagnosis and Prognosis
Chapter 8 Market Breakdown by Region
North America
United States
Canada
Europe
United Kingdom
France
Germany
Spain
Rest of Europe
Asia-Pacific Region
China
Japan
India
Australia
Rest of Asia-Pacific
Rest of the World
Latin America
Middle East and Africa
Chapter 9 Cell Viability Assays Market Industry Structure
Raw Material Suppliers
Quality and Technology
Terms and Conditions
Cost-Effective Components
Manufacturers
Distributors
Raw Material Suppliers of Consumables
Quality
Terms and Conditions
Cost
Manufacturers of Consumables
Distributors of Consumables
End Users of Consumables
Innovation Within the Industry
Competitive Analysis
Chapter 10 Company Profiles
AAT BIOQUEST INC.
ABCAM
ABNOVA CORP.
ANASPEC INC.
BECTON, DICKINSON AND CO.
BIO-RAD LABORATORIES
BIOTEK INSTRUMENTS
BIOTIUM
BIOVISION INC.
CAYMAN CHEMICAL
CORNING INC.
CREATIVE BIOARRAY
DANAHER CORP.
DOJINDO MOLECULAR TECHNOLOGIES INC.
GE HEALTHCARE
INTELLICYT CORP.
MERCK KGAA
MESGEN
MOLECULAR DEVICES LLC
PERKINELMER
PROMEGA CORP.
R&D SYSTEMS INC.
TAKARA BIO INC.
THERMO FISHER SCIENTIFIC
VITASCIENTIFIC

	List of Figures
Summary Figure : Global Cell Viability Assays Market, by Product, 2017-2023
Figure 1 : Research Funding for Biological Science Research Studies, 2017
Figure 2 : Global Tissue Engineering and Cell Therapy Market Growth, 2009-2018
Figure 3 : Global Projections for Deaths from the Top Three Chronic Diseases, 2005-2030
Figure 4 : Worldwide Cancer Incidence Rate, by Type, 2018
Figure 5 : Global Pharmaceutical R&D Spending, 2015-2022
Figure 6 : Pharmaceutical Research and Manufacturers of America Member Company R&D Expenditures, 2010 and 2016
Figure 7 : Cell Viability Assays Market, by Product
Figure 8 : Types of Automated Cell Counters
Figure 9 : dPCR used for Viability of Genetically Modified Organisms (GMOs)
Figure 10 : Types of Consumables in the Cell Viability Assays Market
Figure 11 : Classification of Assay kits
Figure 12 : Conversion of Resazurin to Resorufin to Determine Cell Viability
Figure 13 : Protease Activity Assays
Figure 14 : Global Deaths Due to Cancer, 2018
Figure 15 : Global Oncology Therapeutics Investment, 2011-2021
Figure 16 : Approaches for Bacterial Viability Assessment
Figure 17 : PMA-qPCR Assay and PMA treatment
Figure 18 : Major Growth Factors of Global Cell Viability Assays Market, by Application
Figure 19 : Cell Viability Assay Products Used in Clinical and Diagnostics Application
Figure 20 : Global Cancer Burden, 2012 and 2030
Figure 21 : Global Prevalence of Dementia, 2015-2050
Figure 22 : Evaluation of Cell Viability Using Flow Cytometry Technique
Figure 23 : Global Pharmaceutical Market, 2015 and 2020
Figure 24 : Pharmaceutical Spending as a Percentage of Health Spending, 2016
Figure 25 : Global Biologics Spending, 2011 and 2016
Figure 26 : Global Total of Pharmaceutical R&D Spending, 2015-2022
Figure 27 : Classification of Stem Cells
Figure 28 : NIH Spending on Stem Cell Research, 2014-2018 (Estimated)
Figure 29 : Growing Investment in Different Stem Cell-Based Research in the United States, 2016 and 2017
Figure 30 : Rise in R&D Expenditures in 2018 Compared with 2017
Figure 31 : Global Spending on Life Sciences R&D, 2015-2018
Figure 32 : Top R&D Spending Nations in Europe, 2017 and 2018
Figure 33 : Investment in Research and Innovation Through European Commission Framework Programs, 1984-2027
Figure 34 : Number of Research Grants Received by European Countries, 2018
Figure 35 : R&D Expenditures of the Top 20 Countries in Asia, 2017 and 2018
Figure 36 : Cell Viability Assays End Users
Figure 37 : Major Factors Driving Growth of the Cell Viability Assays Market
Figure 38 : Generalized Scheme Representing an In Vitro Cytotoxicity Assay Protocol
Figure 39 : Methods of Cell Viability Counting Used in Research Institutions
Figure 40 : Usage of Flow Cytometry in the Drug Discovery and Development Process
Figure 41 : U.S. Pharmaceutical R&D Spending, 2005-2015
Figure 42 : R&D Spending by India’s Seven Largest Pharma Companies, 2016
Figure 43 : Death Rates Due to Cancer, 2018
Figure 44 : People Infected with HIV, by Region, 2014-2016
Figure 45 : Malaria Deaths, by Region, 2014-2016
Figure 46 : NIH Spending on Stem Cell Research, 2013-2016
Figure 47 : Healthcare Expenditures in Canada, 2015 and 2040
Figure 48 : Distribution of Annual Budget of Canadian Institute of Health Research, 2016
Figure 49 : Estimated Number of People Living with Cancer in the U.K., 2015 vs. 2020
Figure 50 : Government Funding for Drug-Based Research in France, 2010 and 2016
Figure 51 : Rising Number of Cancer Cases in Spain, 2012 and 2015
Figure 52 : Hospitals and Research Centers Participating in Clinical Trials on Cancer, 2004-2016
Figure 53 : Rising Prevalence of Breast Cancer in Norway, 2014 and 2015
Figure 54 : Number of People with Cancer in China, 2010-2016
Figure 55 : Japanese Pharmaceuticals Industry, 2010-2015
Figure 56 : R&D Spending by Top Seven Pharmaceutical Companies in India, 2018
Figure 57 : Overall ROW R&D Expenditures, by Region, 2016 and 2017
Figure 58 : Deaths in Brazil Due to Cancer, 2010 and 2016
Figure 59 : Capital Raised by Israeli High-Tech Companies, 2013-2017
Figure 60 : Industry Structure of Instruments Used in Cell Viability Assays Market
Figure 61 : Industry Structure of Consumables Used in the Cell Viability Assays Market
Figure 62 : Distribution of Cell Assays Studies Globally, 2018
Figure 63 : Competitive Strategies Used in the Global Cell Viability Assay Market, 2015 and 2018

Related Reports

Rigid-Knee-Braces-Market

Rigid Knee Braces Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

According to 99Strategy, the Global Rigid Knee Braces Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global ...read more

Rigid-Polyurethane-Foam-RPUF-Market

Rigid Polyurethane Foam (RPUF) Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

According to 99Strategy, the Global Rigid Polyurethane Foam (RPUF) Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analys ...read more

Ring-Pessary-Market

Ring Pessary Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

According to 99Strategy, the Global Ring Pessary Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Ring ...read more

Rinse-the-Needle-Market

Rinse the Needle Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

According to 99Strategy, the Global Rinse the Needle Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global ...read more

Rivastigmine-Transdermal-Patches-Market

Rivastigmine Transdermal Patches Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

According to 99Strategy, the Global Rivastigmine Transdermal Patches Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report anal ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Cards For Payment
Trusted Badge SSL Certified Premium Quality

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Intel Samsung 3M BCG LEK Consulting McKinsey Thyssenkrupp Mogensen BASF IQVIA Hella Oracle Accenture Saint Gobain

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.